PR Quardira2

anfass Life Technologies AG and Xlife Sciences AG, based in Zurich, have entered into a joint venture. Together, they founded Quadira Biosciences AG, with access to the 3D CoSeedis™ technology platform of abc biopply ag, a portfolio company of anfass. This unique 3D cell technology enables the replication of human tissue for reliable testing and characterization of antibodies without animal testing.

More information about the 3D CoSeedis™ technology platform:

Learn more about the collaboration here: